Skip to content

Neurology

ISSN 1526-632X

33 papers in the library · 1,533 citations · publishing 1955-2026

Papers

Sort Most recent Most cited

Does the arousal system contribute to near death experience?

Neurology April 10, 2006 Kevin R. Nelson, Michelle Mattingly, Sherman A. Lee et al. 120 citations

The neurophysiologic basis of near death experience (NDE) is unknown. Clinical observations suggest that REM state intrusion contributes to NDE. Support for the hypothesis follows five lines of evidence: REM intrusion during wakefulness is a frequent normal occurrence, REM intrusion underlies other clinical conditions, NDE elements can be explained by REM intrusion, cardiorespiratory afferents...

Memory impairment in now abstinent MDMA users and continued users: A longitudinal follow-up

Neurology March 13, 2006 Konstantine K. Zakzanis, Zachariah Campbell 54 citations

The authors further investigated the functional consequences of continued neurotoxicity of (+/-)3,4-methylenedioxymethamphetamine (MDMA) use. Fifteen participants who were previously given a brief neuropsychological battery were tested for a third time 2 years after baseline. At 2 years, seven participants were still using MDMA, whereas eight participants had become abstinent from MDMA since...

DOI: 10.1212/01.wnl.0000200957.97779.ea (opens in new tab) MDMA Ecstasy Neuropsychology Neuropsychological test +5

Memory impairment in abstinent MDMA (“Ecstasy”) users: A longitudinal investigation

Neurology April 10, 2001 Konstantine K. Zakzanis, Donald A. Young 122 citations

To examine the neurotoxic potential of continued MDMA ("Ecstasy") use in humans and its functional consequences over the course of 1 year, 15 MDMA users participated in a longitudinal study in which they completed a brief neuropsychological test battery composed mainly of retrospective and prospective memory tasks. Subjects were abstinent for 2 weeks on initial and 1-year testing. Continued use...

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

Neurology July 25, 2000 Stephen J. Kish, Yoshiaki Furukawa, Lee-Cyn Ang et al. 119 citations

The authors found that striatal levels of serotonin and those of its metabolite 5-hydroxyindoleacetic acid were severely depleted by 50 to 80% in brain of a chronic user of methylenedioxymethamphetamine (MDMA) whereas concentrations of dopamine were within the normal control range. Our data suggest that MDMA exposure in the human can cause decreased tissue stores of serotonin and therefore some...

Prevalence and pathologic associations of sleep paralysis in the general population.

Neurology April 12, 1999 Maurice Ohayon, J Zulley, Christian Guilleminault et al.

Previous epidemiologic data on sleep paralysis (SP) came from small specific samples. The true prevalence and associated factors of SP in the general population remain unknown. A representative sample of the noninstitutionalized general population of Germany and Italy age > or =15 years (n = 8,085) was surveyed by telephone using the Sleep-EVAL questionnaire and the Sleep Questionnaire of...

Quantitative cerebral blood flow determination

Neurology September 1, 1964 Lawrence C. McHenry 35 citations

Abstract In recent years, specific cortical networks have been proposed to be crucial for sustaining consciousness, including the posterior hot zone and frontoparietal resting state networks (RSN). Here, we computationally evaluate the relative contributions of three RSNs – the default mode network (DMN), the salience network (SAL), and the central executive network (CEN) – to consciousness and...

Frenquel, a Blocking Agent Against Experimental LSD‐25 and Mescaline Psychosis

Neurology May 1, 1955 Howard D. Fabing 41 citations

Background: Patients with ALS commonly exhibit pseudobulbar affect. Methods: The authors conducted a multicenter, randomized, double-blind, controlled, parallel, three-arm study to test a defined combination of dextromethorphan hydrobromide (DM) and quinidine sulfate (Q) (AVP-923) for the treatment of pseudobulbar affect in ALS. Q inhibits the rapid first-pass metabolism of DM. The effects of...

DOI: 10.1212/wnl.5.5.319 (opens in new tab) Discontinuation Dextromethorphan Randomized controlled trial Adverse effect +2